Voutsadakis相关文献与解析，生知库 | 链接生命科学的每一步

The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer

泛素化对p53的调控及其在结直肠癌治疗靶向中的意义

期刊:Genes

影响因子:2.8

doi:10.3390/genes17030270

Voutsadakis, Ioannis A

Dihydropyrimidine dehydrogenase (DPYD) genetic testing and treatment with 5-fluoropyrimidines in cancer patients: prevalence of variants with decreased activity and chemotherapy outcomes

癌症患者二氢嘧啶脱氢酶 (DPYD) 基因检测及 5-氟嘧啶类药物治疗：活性降低变异体的患病率及化疗疗效

期刊:Pharmacogenomics

影响因子:1.9

doi:10.1080/14622416.2026.2641748

Rosso, Christopher; Febbraro, Michela; Voutsadakis, Ioannis A

Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review

转移性雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中细胞周期蛋白依赖性激酶4和6抑制剂原发性和继发性耐药的生物标志物：叙述性综述

期刊:Translational Breast Cancer Research

影响因子:1.4

doi:10.21037/tbcr-25-17

Stravodimou, Athina; Voutsadakis, Ioannis A

Transient Receptor Potential Channels in Prostate Cancer: Associations with ERG Fusions and Survival

前列腺癌中的瞬时受体电位通道：与ERG融合和生存率的关系

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms26083639

Murugan, Nirosha J; Genautis, Emma; Voutsadakis, Ioannis A

Clinical and Pathological Features and Survival Outcomes of Breast Cancers with Intermediate ER Expression

雌激素受体（ER）表达中等的乳腺癌的临床病理特征和生存结局

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers17132252

Hammond, Jonathan; Lambert, Nicholas; Voutsadakis, Ioannis A

Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report

两种不同的成纤维细胞生长因子受体抑制剂治疗携带FGFR2突变的肝外胆管癌患者的疗效：病例报告

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyae294

Galli-Vareia, Ilianna; Szturz, Petr; Voutsadakis, Ioannis A; Villard, Nicolas; Tsoumakidou, Georgia; Fleury, Mapi; Herrera, Gabriela; Fasquelle, Francois; Godat, Sebastien; Digklia, Antonia

ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network

ETS家族转录因子在胃癌中的作用以及ELF3在核心化生转录因子网络中的作用

期刊:Oncology Research

影响因子:4.1

doi:10.32604/or.2025.069230

Voutsadakis, Ioannis A

Molecular alterations in claudin 18 suppressed and non-suppressed gastric adenocarcinomas to guide targeted therapies

利用 Claudin 18 抑制和非抑制胃腺癌的分子改变指导靶向治疗

期刊:Tissue Barriers

影响因子:4

doi:10.1080/21688370.2024.2348852

Voutsadakis, Ioannis A

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

病例报告：帕博利珠单抗治疗错配修复缺陷型心脏肉瘤获得持久完全缓解：基因组特征分析

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1485386

Ferraro, Daniela A; Bisig, Bettina; Rotzinger, David C; Pareja, Fresia; Missiaglia, Edoardo; Voutsadakis, Ioannis; Homicsko, Krisztian; Digklia, Antonia

发表日期：2025

文献求助收藏

From PIK3CA Mutations to Rational PI3K Inhibition for the Treatment of Colorectal Cancer

从PIK3CA突变到合理应用PI3K抑制剂治疗结直肠癌

The Regulation of p53 by Ubiquitination and Implications for Therapeutic Targeting in Colorectal Cancer

泛素化对p53的调控及其在结直肠癌治疗靶向中的意义

Dihydropyrimidine dehydrogenase (DPYD) genetic testing and treatment with 5-fluoropyrimidines in cancer patients: prevalence of variants with decreased activity and chemotherapy outcomes

癌症患者二氢嘧啶脱氢酶 (DPYD) 基因检测及 5-氟嘧啶类药物治疗：活性降低变异体的患病率及化疗疗效

Biomarkers of primary and secondary resistance to cyclin dependent kinases 4 and 6 inhibitors in metastatic estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast cancer: a narrative review

转移性雌激素受体阳性/人表皮生长因子受体2阴性乳腺癌中细胞周期蛋白依赖性激酶4和6抑制剂原发性和继发性耐药的生物标志物：叙述性综述

Transient Receptor Potential Channels in Prostate Cancer: Associations with ERG Fusions and Survival

前列腺癌中的瞬时受体电位通道：与ERG融合和生存率的关系

Clinical and Pathological Features and Survival Outcomes of Breast Cancers with Intermediate ER Expression

雌激素受体（ER）表达中等的乳腺癌的临床病理特征和生存结局

Efficacy of 2 different fibroblast growth factor receptor-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation: a case report

两种不同的成纤维细胞生长因子受体抑制剂治疗携带FGFR2突变的肝外胆管癌患者的疗效：病例报告

ETS Family Transcription Factors in Gastric Cancer and the Role of ELF3 in the Core Metaplasia Transcription Factor Network

ETS家族转录因子在胃癌中的作用以及ELF3在核心化生转录因子网络中的作用

Molecular alterations in claudin 18 suppressed and non-suppressed gastric adenocarcinomas to guide targeted therapies

利用 Claudin 18 抑制和非抑制胃腺癌的分子改变指导靶向治疗

Case Report: Lasting complete response to pembrolizumab in mismatch repair-deficient cardiac sarcoma: a genomic characterization

病例报告：帕博利珠单抗治疗错配修复缺陷型心脏肉瘤获得持久完全缓解：基因组特征分析